Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NAVCO Pharmaceuticals Inc (TSE:NAV)
TSXV:NAV
NAVCO Pharmaceuticals Inc (NAV) Stock Price & Analysis
1 Followers
NAV Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.10
Previous CloseC$0.04
Volume2.06K
Average Volume (3M)43.00K
Market Cap
C$1.61M
Enterprise ValueC$1.64M
Total Cash (Recent Filing)C$79.60K
Total Debt (Recent Filing)C$108.26K
Price to Earnings (P/E)>-0.1
Beta0.23
Next Earnings
May 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding57,069,541
10 Day Avg. Volume12,506
30 Day Avg. Volume43,002
Standard Deviation0.26
R-Squared0.01
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-7.81
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NAVCO Pharmaceuticals Inc News
PremiumCompany Announcements
NAVCO Pharmaceuticals Boosts Investor Outreach
PremiumCompany Announcements
NAVCO Pharmaceuticals Grants Stock OptionsOptions Prices
Currently, No data available
---
Ownership Overview
0.74%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
99.26% Public Companies and
Individual Investors
NAV FAQ
What was NAVCO Pharmaceuticals Inc’s price range in the past 12 months?
NAVCO Pharmaceuticals Inc lowest stock price was C$0.02 and its highest was C$0.10 in the past 12 months.
What is NAVCO Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is NAVCO Pharmaceuticals Inc’s upcoming earnings report date?
NAVCO Pharmaceuticals Inc’s upcoming earnings report date is May 28, 2024 which is in 10 days.
How were NAVCO Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is NAVCO Pharmaceuticals Inc overvalued?
According to Wall Street analysts NAVCO Pharmaceuticals Inc’s price is currently Overvalued.
Does NAVCO Pharmaceuticals Inc pay dividends?
NAVCO Pharmaceuticals Inc does not currently pay dividends.
What is NAVCO Pharmaceuticals Inc’s EPS estimate?
NAVCO Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NAVCO Pharmaceuticals Inc have?
NAVCO Pharmaceuticals Inc has 40,350,440 shares outstanding.
What happened to NAVCO Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NAVCO Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in TSE:NAV
---
NAVCO Pharmaceuticals Inc Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-42.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
434.24%
Trailing 12-Months
Company Description
NAVCO Pharmaceuticals Inc
BMGB Capital Corp is a capital pool company.
---
Technical Analysis
---